TET2 and atherosclerosis: When manipulating protective care approaches to address the impact of CHIP on atherosclerosis, it is essential to consider the mechanistic distinctions between TP53/PPM1D-CHIP and DNMT3A/TET2/ASXL1/JAK2-CHIP.